Loading...
Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
Hydroxychloroquine has been used worldwide as a first-line treatment for patients hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with congenital red blood cell disorders. We report a case of haemolytic anaemia in a 32-year-old patient and a fortuitous highligh...
Na minha lista:
| Udgivet i: | Eur J Case Rep Intern Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SMC Media Srl
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7473690/ https://ncbi.nlm.nih.gov/pubmed/32908842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001875 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|